MARC details
| 000 -LEADER |
|---|
| fixed length control field |
05229nam a22003974i 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
013731502 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
EG-GaU |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20210706125311.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
061106s2007 it a b 001 0 eng c |
| 010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
|---|
| LC control number |
2006938039 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9788847004917 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
8847004918 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
NLM |
| Language of cataloging |
eng |
| Description conventions |
rda |
| Transcribing agency |
NLM |
| Modifying agency |
OHX |
| -- |
C3L |
| -- |
BAKER |
| -- |
YDXCP |
| -- |
DLC |
| -- |
Uk |
| -- |
EG-GaU |
| 041 1# - LANGUAGE CODE |
|---|
| Language code of text/sound track or separate title |
eng |
| Language code of original |
ita |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Edition number |
23 |
| Classification number |
610.72 |
| Item number |
B.A.F. |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Bacchieri, Antonella, |
| Relator term |
author |
| 9 (RLIN) |
858 |
| 240 10 - UNIFORM TITLE |
|---|
| Uniform title |
Fondamenti di ricerca clinica |
| Language of a work |
English |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Fundamentals of clinical research : |
| Remainder of title |
bridging medicine, statistics, and operations / |
| Statement of responsibility, etc. |
Antonella Bacchieri, Giovanni Della Cioppa. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Place of production, publication, distribution, manufacture |
Milano : |
| Name of producer, publisher, distributor, manufacturer |
Springer, |
| Date of production, publication, distribution, manufacture, or copyright notice |
[2007] |
| 264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Date of production, publication, distribution, manufacture, or copyright notice |
©2007 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xxv, 343 pages : |
| Other physical details |
illustrations ; |
| Dimensions |
25 cm |
| 336 ## - CONTENT TYPE |
|---|
| Content type term |
text |
| Source |
rdacontent |
| Content type code |
txt |
| 337 ## - MEDIA TYPE |
|---|
| Media type term |
unmediated |
| Source |
rdamedia |
| Media type code |
n |
| 338 ## - CARRIER TYPE |
|---|
| Carrier type term |
volume |
| Source |
rdacarrier |
| Carrier type code |
nc |
| 490 1# - SERIES STATEMENT |
|---|
| Series statement |
Statistics for biology and health |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc. note |
Includes bibliographical references (pages [331]-335) and index. |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
1. Variability of Biological Phenomena and Measurement Errors1.1. Phenotypic Variability 1.2. Temporal Variability.1.3. Measurement - Related Variability 1.3.1. The Measurement 1.3.2. Measurement Errors 1.4. Variability of Diagnostic Tests Summary 2. Distinctive Aspects of a Biomedical Study. Observational and Experimental Studies 2.1. Distinctive Features of Biomedical Studies 2.2. The Study Protocol 2.3. Observational Studies2.4. Experimental StudiesSummary 3. Observational Studies3.1. Basic Designs of Observational Studies 3.1.1. Prospective or Cohort Studies3.1.2. Retrospective Studies or Control Cases 3.1.3. Sample Size3.2. Bias and Confounding 3.2.1. Control of Bias in Epidemiology 3.2.2. Control of the Phenomenon of Confounding |3.3. Advantages and Disadvantages of the Different Types of Observational Studies Summary 4 Defining the Treatment Effect 4.1. From the Single Measurement to the Signal 4.2. Identification and Quantification of the End-Points (Individual Subject Level)4.2.1. Methodological Characteristics of the End-Point 4.2.2 Discriminating Between Primary and Secondary End-Points and Between Efficacy and Safety/Tolerability End-Points 4.3. Identification and Quantification of the Signals (Group Level) 4.4. Statistical Considerations 4.5. Practical, Regulatory, Marketing and Pharmaco-Economic Considerations 4.6. Selection and Characterization of the Primary End-Point and Signal: an Example 4.6.1. Stage One: Define the Main Therapeutic Level 4.6.2. Stage Two: Define the Primary End-Point (Individual Patient Level) 4.6.3. Stages Three and Four: Define the Group Indicator, the Signal, and the Threshold of Clinical Relevance (Treatment Group and Study Levels) 4.7. More Than One Question in the Same Study: the Problem of Multiple Statistical Tests 4.8. Validation of Measurement Scales 4.9. Special Types of End-Points Summary 5. Probability, Inference and Decision Making 5.1. Probability 5.1.1 Definitions 5.1.2. Probability Distribution and Probability Density Function5.1.3. Normal or Gaussian Distribution5.2. Basic Concepts of Inference 5.2.1. Hypothesis Testing and Statistical Formulation of the Medical Question 5.2.2. Statistical Estimation as the Tool for Evaluation of Clinical Relevance 5.3. Statistical Inference in the Frequentist and the Bayesian Approaches5.4. Two Digressions: Measures of Variability and Likelihood Function 5.4.1. Measures of Variability5.4.2. Likelihood Function 5.5. Frequentist (Classical) Analysis of a Clinical Trial 5.5.1. Hypothesis Testing: the Frequentist Solution5.5.2. Estimation of the Effect: the Frequentist Solution 5.6. Bayesian Analysis of a Clinical Trial 5.6.1. Hypothesis Testing: the Bayesian Solution 5.6.2. Estimation of the Effect: the Bayesian Solution5.7. Some Additional Considerations on the Frequentist and Bayesian Approaches 5.8. Parametric and Non-Parametric Inference5.9. Statistical Decision Making in the Medical Field 5.10. Evidence-Based Medicine Summary 6. The Choice of the Sample 6.1. Which Subjects Should Form the Sample? 6.1.1. Characteristics of the Patients to be Enrolled in the Study6.1.2. Mechanism of Subject Selection 6.2. How Many Subjects Should Form the Sample? 6.2.1. Statistical Considerations 6.2.2. Medical and Practical AspectsSummary 7. The Choice of Treatments 7.1. Study Treatments7.1.1. How Many Treatments 7.1.2. What Treatments7.1.3. Blinding of the Study Treatments 7.1.4. Packaging and Logistics7.2. Concomitant TreatmentsSummary 8. Experimental Design: Fallacy of 'Before-After' Compa. |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
Here is a new book on methods and issues in clinical research. Integrate medical and statistical components of clinical research. Give space to the ethical implications of methodological issues in clinical research. The book ends with a brief description of the drug development process and the phases of clinical development. |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Medicine |
| General subdivision |
Research. |
| 9 (RLIN) |
859 |
| Source of heading or term |
GU-sh |
| 650 17 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Biomedical Research |
| General subdivision |
methods. |
| 9 (RLIN) |
860 |
| Source of heading or term |
GU-sh |
| 650 27 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Research Design. |
| 9 (RLIN) |
861 |
| Source of heading or term |
GU-sh |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Della Cioppa, Giovanni. |
| 9 (RLIN) |
862 |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE |
|---|
| Uniform title |
Statistics for biology and health. |
| 9 (RLIN) |
863 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Koha item type |
Books |
| Source of classification or shelving scheme |
Dewey Decimal Classification |